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Effect of chiorpropamide on water and urea transport in the inner
medullary collecting duct. The present in vitro microperfusion study
examined whether chlorpropamide (CPM) has a direct effect on hydrau-
lic conductivity (Lp x 10—6 cm/atm . see) and '4C-urea permeability (Pu
x iO cm/sec) in the middle and distal inner medullary collecting duct
(IMCD) obtained from acutely water-loaded Wistar rats and rats
homozygous for diabetes insipidus (DI). CPM (10 M) added to the
bath fluid increased the Lp in the water-loaded Wistar rats from —0.05
0.13 to 6.25 0.74 (p <0.01) and in the DI rats from 0.05 0.01 to
5.95 0.84 (p < 0.01), but had no effect when it was added to the
perfusate. CPM stimulated Lp in a dose-dependent manner with the
threshold effect at 10-6 54. However, the addition of CPM (l0— M) to
submaximal concentration of VP in the bath fluid did not increase the
Lp. Furthermore, CPM was unable to block the inhibitory action of
PGE2 on the vasopressin (VP)-stimulated Lp. On the contrary, PGE2
blocked the CPM-stirnulated Lp. CPM (10—a si) in the pentubular fluid
was able to cause a significant rise of the Pu from 13.5 0.8 to 17.3
1.0 reversibly, which represented 16% of maximum stimulated effect
produced by 50 U/ml of VP. Thus, pharmacological doses of CPM
added to the peritubular side have a direct effect on terminal IMCD
increasing water and urea permeability in the absence of VP, but this
drug does not potentiate the VP-stimulated water transport in the
IMCD. Our results were unable to confirm the hypothesis that CPM
potentiates the VP-antidiuresis by the inhibition of PGE2 action in the
rat IMCD.
Chiorpropamide (CPM), a sulfonylurea derivative, has been
shown to reduce urine flow in some patients with diabetes
insipidus (DI). Arduino, Ferraz and Rodrigues [1] reported a
decrease in urinary volume and an increase in urine osmolality
following administration of CPM to patients with diabetes
insipidus of pituitary origin. A number of studies have shown
that this drug also has an antidiuretic action in water-loaded
normal subjects [2, 3] and in patients with diabetes mellitus [4].
The precise mechanism of CPM antidiuresis has not yet been
elucidated. Three possible hypothesis have been suggested:
first, stimulation of ADH release from the posterior pituitary
gland [51, but some studies [6, 71 found no evidence for such an
effect; second, ADH-like action and; third, potentiation of the
antidiuretic effect of suboptimal levels of ADH at the renal
tubule [8—10]. Studies in Brattleboro DI rats suggest that CPM
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reveals its antidiuretic effect by potentiating the action of ADH
present in very small amounts in patients with diabetes insipi-
dus [9, 10].
There is considerable disagreement in the literature regarding
the existence of a direct effect of CPM on osmotic water flow
across the toad bladder. Several investigators found a signifi-
cant increase in osmotic water flow after the addition of CPM in
high concentrations (3 to 6 mM) [11, 12], while others found an
extremely small or no increase in the presence of low doses of
CPM (1 m or less) [13, 14]. It is conceivable that the
discrepancy between these studies may reflect differences in the
sensitivity of different types of toad bladders to CPM and/or
differences in the CPM concentrations tested.
The antidiuretic action of CPM could be due to an increase in
the activation of adenylate cyclase by arginine vasopressin
(VP). The hypothesis was based upon studies in which toad
bladder or renal medullary cell membranes [8, 15—17] were
prepared in the presence of or after treatment with CPM,
leading to an increase in renal cAMP concentration. Since there
is a VP-sensitive adenylate cyclase in both the mammalian
collecting tubule and the thick ascending limb of Henle's loop
[18], the effect of CPM on enhancing VP-stimulated adenylate
cyclase could occur at either or both sites.
Recent studies have demonstrated that inhibition of prosta-
glandin synthesis greatly enhances the VP-stimulated water
permeability in the collecting tubules and sodium transport in
the thick ascending limb of Henle's loop [19, 20]. Since CPM
appears to inhibit VP-stimulated prostaglandin E2 (PGE2) syn-
thesis in the toad bladder [12], there is the hypothesis that the
antidiuretic effect of CPM is due to an inhibition of PGE2
biosynthesis.
Therefore, many points regarding the proposed CPM action
on urinary concentration still remain to be clarified. In partic-
ular, it remains to be determined whether CPM acts on renal
tubules directly or through some secondary mechanism after its
administration in vivo.
The goal of the present study was to analyze directly the
effect of CPM on hydraulic conductivity (Lp) and urea perme-
ability (Pu) of the inner medullary collecting duct (IMCD)
obtained from acutely water-loaded and DI rats, using the in
vitro microperfusion technique. This method permitted a mea-
surement of the capacity of CPM to potentiate the VP-stimu-
lated Lp of IMCD and to determine the effect of CPM on Lp in
the presence of PGE2 synthesis inhibition.
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Methods
Isolated inner medullary collecting duct (IMCD) segments
were perfused by routine techniques previously described [211.
Kidneys from Wistar rats and homozygous rats of the Brattle-
boro strain (DI rats) weighing 120 to 125 g, fed a standard chow
(Na = 184 mEqlkg), were obtained and tubules were isolated
from a small slice immersed in a dish of chilled Ringer/HCO3
buffer, oxygenated and kept at pH 7.4 by bubbling the solution
with 5% CO2 and 95% 02. The IMCD segments were dissected
without the use of collagenase or other enzymatic agents. The
papillary middle third (IMCD2) and inner third (IMCD3) seg-
ments were isolated from the terminal two-thirds where the
urea permeability is higher [22]. The tubules were mounted on
concentric pipettes as described previously [21] and were
studied at 37°C. One end of a single segment was drawn by
suction into the tip of a glass-holding pipette. An inner pipette
was then advanced into the duct lumen. This pipette contained
the solution to be perfused through the duct. Perfusion was
driven by hydrostatic pressure. The opposite end of a single
tubule or two branches was held in another glass micropipette
made according to the size of the branches to avoid leak
between them. A viscous silicone liquid (Sylgard 184, Dow
Corning Corp., Midland, Michigan, USA) was used to form a
seal around the branches which completely separates the col-
lected fluid from the bath solution. At intervals, the collected
fluid was removed by a sampling pipette which had its volume
measured before the onset of the experiment. The mean dura-
tion of the collection periods was 10 minutes. Unless indicated
otherwise, Ringer/HCO3 buffer (composition in mM: NaCI, 115;
NaHCO3, 25; Na acetate, 10; KCI, 5; CaCI2, 1.0; MgSO4, 1.2;
NaH2PO4, 1.2; glucose, 5.5 without urea) was used as the bath
and perfusion solution.
Net water absorption (J) was measured with '4C-inulin or
3H-inulin dialyzed immediately before the experiments. The
dialyzed isotope was added to the perfusion solution to give a
final concentration of 25 to 100 cpm/nl. No leakage of radioac-
tive inulin into the bath fluid was detected. J,. was calculated as
(V-V0/l) where V1 was the perfusion rate, V0 the collection rate
and 1 the length of tubule studied (tubule length and inner
diameter can be measured to within 0.05 mm with a precali-
brated micrometer in one eyepiece of the inverted microscope
used to observe the perfusion). V0 was directly measured by
using the collection time while V. was calculated by the
equation: V = V0(In0/In), where In0 is 14C or 3H-inulin cpm/nl
of the collected fluid and In1 is cpm/nl of the perfusate. Timed
tubular samples were collected for analysis under mineral oil by
aspiration with a calibrated pipette. All measurements were
obtained 60 to 90 minutes after onset of perfusion of a given
nephron segment. The internal diameter of the perfused seg-
ments varied from 25 to 35 and the tubular length from 1.5 to
3.0 mm.
Hydraulic conductivity (Lp) was determined by measuring
net fluid movement in response to an imposed osmotic gradient
in the absence and in the presence of VP. Net fluid absorption
was induced by perfusion with a hypotonic solution of 80 to 90
mOsm/kg . H20 (NaC1 50 mM) and a 300 mosm/kg H2O bath
solution. Rapid perfusion rates of 20 to 40 nI/mm were used to
avoid osmotic equilibrium between perfusate and bath. Osmo-
lalities of perfusate and bath fluid were measured, and Lp
(cm s atm1) was calculated in each experiment by the
following equation [23]:
Lp = l/RTACb2 {Cb(V1 — V0) + CiV1 [ln(Cb — Ci) V
— in (CbV0 — C1V1)]} (1)
where Cb and Ci are the osmolalities of the bath fluid and the
perfusate, respectively, V1 the perfusion rate, V0 the collection
rate, R, the gas constant, and T the absolute temperature, and
A the luminal surface area. This equation is based on the
assumption that the reflection coefficient of NaC1 is 1.0 [23]. No
change in the reflection coefficient of NaCI was seen to occur
after exposure to VP and CPM, since the sodium bath-to-lumen
permeability of IMCD was found to be similar to control values
in the presence of CPM (1.83 0.13 vs. 1.84 0.15 x l0—
cm/sec) and VP [24]. The computation of the Lp of tubules with
two branches in parallel showed that the Lp calculated for each
branch does not differ from the Lp calculated by the equation 1
using the total area as the sum of the surface of each branch and
the collected fluid (nllmin) as the sum of the collected volume of
each segment.
Passive urea permeability from lumen-to-bath (Pu) was esti-
mated from the disappearance rate of '4C-urea (50 to 100
cpm/nl) from the perfusion solution. When there was no net
volume absorption, permeability from lumen-to-bath was cal-
culated from the following equation:
V, Ci
Pu=ln—' (2)
where V, is the perfusion rate, A is the inner surface area of the
tubule and Ci and Co are the activities of '4C-urea (cpmlnl), in
the initial perfusion fluid and the collected fluid, respectively. In
the case in which net volume reabsorption was present, Pu was
computed from the following equation [25]:
(3)
where the characters are the same as in equations 1 and 2
except that au is the reflection coefficient of urea being consid-
ered equal to 1.0 [26]. Similarly to what was described above for
Lp, we demonstrated that Pu calculated for each branch is
identical to the Pu obtained by equation (2) using the total area
and the total collected volume as the sum of the area surface
and the collected volume of each branch.
Perfusate and bath fluids were checked for sodium and
potassium concentration, osmolality and pH with the Na-K
flame photometer, model 143 (Instrumentation Laboratory,
Inc., Lexington, Massachusetts, USA), osmometer (Advanced
Instruments Inc.) and pH meter (Iris 7 Tecnow), respectively.
The bath fluid was changed every five to seven minutes in order
to reduce the effect of evaporation and consequently the
increase in osmotic gradient. The bath osmolality did not
change significantly during the seven minute period, from 296
2 at 0 mm to 294 1 at seven minutes.
Timed fluid collections were made with a constant volume
constriction pipette which was rinsed four times with 0.5 ml of
water and 5 ml of scintillation liquid was then pipetted into the
vial (Aquasol Universal Cocktail, New England Nuclear, Bos-
ton, Massachusetts, USA). The isotopic concentration was
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Table 1. Effect of chiorpropamide added to the bath fluid on hydrosmotic conductivity in IMCD of Wistar rats
Control Chiorpropamide 10 M Recovery
Osm Osm Osm
Exp T. length Area V J grad Lp V J grad Lp V. J grad Lp
1 2.3 19.3 28.1 —0.07 214 —0.22 27.8 2.29 206 8.44 27.0 —0.07 214 —0.25
2 2.0 23.9 27.4 —0.07 214 —0.17 31.9 2.28 207 5.69 27.8 —0.06 214 —0.07
3 3.0 25.3 26.6 —0.08 214 —0.17 30.7 2.08 207 7.51 26.4 —0.19 214 —0.32
4 3.3 28.9 27.6 —0.00 214 —0.01 32.1 1.42 207 5.14 29.9 +0.70 211 +2.48
5 3.8 31.3 27.7 0.11 213 0.43 31.6 1.56 207 4.49 27.4 +0.05 214 +0.29
Mean 2.9 25.7 27.5 —0.02 214 —0.05 30.8 1.93a 207 6.25a 27.7 +0.09 213 0.43
0.3 2.1 0.2 0.03 0.2 0.13 0.8 0.18 0.2 0.74 0.6 0.16 0.6 0,52
Abbreviations are: T. length, tubular length (mm); Area, tubular area (x lO cm2); V,, perfusion rate (nI/mm); J.,,, net water absorption
(ni/mm mm); Osm grad, osmotic gradient (mOsm/kg H20) and Lp, hydrosmotic conductivity (x 106 cm/atm sec).
a p < 0.01
Table 2. Effect of chlorpropamide added to the perfusate on hydraulic conductivity in IMCD of Wistar rats
Exp T. length Area
Control Chiorpropamide iO M Recovery
V,
OsmJ grad Lp V OsmJ,. grad Lp V, J Osmgrad Lp
1
2
3
4
Mean
2.5
2.1
2.5
2.9
2.5
0.2
26.1
23.5
22.9
28.9
25.3
1.4
24.2
24.4
24.3
24.4
24.4
0.0
0.01 200
0.00 200
0.00 200
0.03 200
0.01 200
0.01 0.0
0.32
0.05
0.03
0.91
0.33
0.25
23.5
23.6
23.7
24.0
23.7
0.1
—0.45 201 —0.47
—0.06 200 —0.03
0.00 200 0.03
0.04 200 —0.01
—0.12 200 —0.12
0.11 0.2 0.10
24.4
24.3
24.4
24.4
24.4
0.0
0.00
—0.00
0.00
—0.04
—0.02
0.01
200
200
200
200
200
0.0
—0.06
—0.01
+0.05
—0.36
—0.09
0.09
Abbreviations are: T. length, tubular length (mm); Area, tubular area (x l0 cm2); V1, perfusion rate (nI/mm); J, net water absorption
(ni/mm. mm); Osm grad, osmotic gradient (mOsm/kg. H20) and Lp, hydraulic conductivity (x 106 cm/atm sec).
determined in a liquid scintillator spectrometer (Beckman,
mod. La-l00-C). When 14C-urea and 3H-inulin were determined
in the same sample, after background subtraction, counts were
corrected for incomplete discrimination between the two chan-
nels.
To avoid the possibility of inulin binding to glass, all glass-
ware in contact with the perfusion solution and collected fluid
was siliconized.
VP and CPM and PGE2 were purchased from Sigma Chem-
ical (St. Louis, Missouri, USA) and were of analytical grade.
The isotopic materials used were provided by Amersham Inter-
national and New England Nuclear.
The results are expressed as mean SEM. The data for each
period are the mean of three to four collections. Statistical
analysis was performed by paired or nonpaired 1-test and by
analysis of variance when appropriate. The data of each tubule
are the mean of three to four collection periods per tubule,
depending on the experimental protocol.
Results
The effect of CPM on water transport of IMCD was analyzed:
first, in Wistar rats with minimum urine osmolality (U0sm = 85
6 mOsm/kg. H20) after acute water-load performed by
intraperitoneal infusion of hypotonic saline (NaCI 75 mM) in a
volume equivalent to 20% of body weight two or three hours
prior to sacrifice; second, in rats of the Brattleboro strain with
hereditary DI allowed free access to tap water (U0sm = 195
20 mOsm/kg . HO).
Effect of CPM on water transport in IMCD obtained from
Wistar rats
The effect of CPM added to the bath fluid (10 M) on
hydraulic conductivity (Lp x 106 cm/atm . sec) is presented in
Table 1. In this group, we measured the effect of CPM on net
water absorption of IMCD in the presence of osmotic gradient.
CPM added to the bath fluid (10—a M) increased water absorp-
tion from —0.02 0.03 to 1.93 0.18 nllmin . mm, which
represented an increase in Lp from —0.05 0.13 to 6.25 0.74
(P < 0.01). The reversibility of the effect was observed restor-
ing the initial condition in the third period when the net water
absorption and Lp returned to 0.09 0.16 and 0.43 0.52,
respectively.
In another group of IMCD, we examined the effect of CPM
(10 M) added to the perfusate on Lp (Table 2). The absence of
net water absorption observed in the control period, in the
presence of osmotic gradient, did not alter significantly by the
addition of CPM to the perfusate (0.01 0.01 vs. —0.12 0.11
nI/mm. mm). These experiments indicated that CPM (10—a M)
was able to increase Lp when it was present in the bath fluid but
not in the luminal fluid.
To test whether CPM added in a lower concentration to the
bath fluid could stimulate Lp in the IMCD, we measured the
effect of CPM 108 M, 106 M, and i0 M. Figure 1 illustrates
these results during five consecutive periods in which Lp was
measured in the absence of VP in the bath. CPM at 10_6 M
increased Lp from —0.06 0.03 to 2.05 0.20 (P < 0.01), but
at 108 M had no effect on Lp (—0.06 0.03 vs. —0.03 0.05).
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Control 108M 10—6M 10-4M
CPM CPM CPM
Fig. 1. Dose response of chiorpropamide (CPM) on hydraulic conduc-
tivity (Lp) of inner medullary collecting duct (IMCD) obtained from
Wistar rats. The experiments were carried out according to the indi-
cated sequence. Each point represents one period. Lines connect data
points of individual tubules. < 0.01
To compare the magnitude of the CPM effect with the
VP-stimulated water absorption in the presence of osmotic
gradient, we measured the net water absorption and Lp during
the control period and after 3 x i0', 10— 12, 10_lI M of VP
added successively to the bath fluid (N = 5). Figure 2 shows
that the stimulated effect of i0" M of CPM on Lp (N = 5) was
similar to the effect of 3 x 10_12 M of VP, and the magnitude of
Lp produced by 10_6 M of CPM was similar to the action of 3 X
i0 M of VP.
In an attempt to test the hypothesis that CPM increases net
water absorption due to an inhibitory effect on PGEe, we first
analyzed directly the effect of CPM on PGE2-inhibited, VP-
stimulated water permeability in five consecutive periods. Fig-
ure 3 shows that Lp increased from 0.01 0.08 to 3.52 0.03
by the addition of submaximal doses of vasopressin (3 x 10_12
M) and decreased to 2.48 0.03 when PGE2 (l0— M) was added
to VP in the bath, but CPM (10—n M), in combination with PGE2
and VP in the bath, did not change the Lp (2.40 0.04) which
remained when CPM was withdrawn. Therefore, this group of
experiments demonstrated that CPM was unable to block the
inhibitory of PGE2 on VP-stimulated Lp in the IMCD.
In the second step, we analyzed the effect of PGE2 on the
CPM-stimulated Lp. Each IMCD was studied during four
consecutive periods: control, in the presence of PGE2 in the
bath fluid, when CPM was added to the PGE2 in the bath, and
finally when PGE2 was withdrawn remaining CPM in the bath
(Table 3). We observed that PGE2 did not change the net water
absorption (0.02 0.03 vs. —0.04 0.02 nI/mm . mm) observed
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Recovery Fig. 2. Comparison between the magnitude of chlorpropamide (CPM)(LI) vasopressin (VP)-stimulated hydraulic conductivity (Lp) (A) and
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experimental group of IMCD. ((p < 0.01, **p < 0.05
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Fig. 3. The effect of chlorpropamide (CPM) on the inhibitory effect of
PGE2 on vasopressin-stimulated hydraulic conductivity (Lp) of IMCD
obtained from Wistar rats. Each IMCD was studied in five consecutive
periods: control (CON), in the presence of AVP (3 x 10-12 M), when
PGE2 was added to VP in the bath, when CPM (l0— M) was associated
to the VP and PGE2 in the bath fluid and finally, when CPM was
withdrawn from the bath and VP plus PGE2 remained. Each point
represents the mean SEM of the values of four tubules obtained in
each period. * 0.01
in the control period, showing that PGE2 did not alter the basal
water permeability, but it was able to block the stimulating
effect of CPM (l0 M) on water absorption (0.08 0.04
nl/min . mm) and Lp (0.26 0.14). In the last period when this
drug was present in the bath in the absence of PGE2, the Lp
increased to 5.99 0.49.
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Table 3. Effect of chiorpropamide (10 M) addition to the bath fluid in the presence of prostaglandin E2 on hydrosmotic conductivity in
IMCD of Wistar rats
T.
Control Prostaglandin E2 105M Prostag. + Chiorprop. Chlorpropamide 104M
Osm Osm Osm Osm
Exp length Area V1 i, grad Lp V1 J grad Lp V1 i, grad Lp V1 i grad Lp
1 2.55 22.9 25.9 0.03 216 0.20 25.1 —0.04 216 —0.14 25.7 0.04 216 0.09 30.0 1.98 207 6.91
2 2.55 24.3 26.5 0.08 216 0.26 25.6 —0.13 216 —0.16 26.9 0.28 215 0.89 30.7 2.03 208 6.69
3 2.75 20.6 25.5 0.07 216 0.26 25.6 —0.03 216 —0.08 25.8 0.00 216 0.02 30.5 1.69 208 7.06
4 3.45 29.0 26.1 0.04 216 0.15 25.9 0.01 216 +0.04 26.1 0.07 215 0.24 31.3 1.61 207 6.03
5 2.40 20.6 25.9 0.02 215 0.07 27.1 —0.09 216 —0.14 26.2 0.12 215 0.42 29.1 1.45 210 5.25
6 2.80 26.3 25.8 0.13 216 —0.14 27.2 +0.01 216 +0.01 26.0 —0.01 216 —0.08 29.0 3.44 210 3.98
Mean 2.75 23.9 25.9 0.02 216 0.13 26.1 —0.04 216 —0.08 26.1 0.08 215 0.26 30.1 2.03 208 599k
0.10 1.36 0.1 0.03 0.2 0.06 0.4 0.02 0 0.04 0.2 0.04 0.2 0.14 0.4 0.29 0.6 0.49
Abbreviations are: T. length, tubular length (mm); Area, tubular area (x l0 cm2); V, perfusion rate (nI/mm); iv, net water absorption
(nl/min mm); Osm grad, osmotic gradient (mOsm/kg. H20) and Lp, hydrosmotic conductivity (X 10-6 cm/atm. sec).
a p 0.01
Table 4. Effect of chlorpropamide (10 M) addition to the bath fluid on hydraulic conductivity of IMCD obtained from diabetes insipidus rats
Exp T. lenght Area
Control Chlorpropamide Recovery
V1
OsmJ grad Lp V, Osmiv grad Lp V1 Osmv grad Lp
1
2
3
4
5
Mean
2.1
2.0
3.8
3.3
3.3
2.9
0.3
22.0
23.6
31.3
28.9
37.7
28.7
2.8
20.8
21.5
27.7
27.6
21.5
23.8
1.6
—0.08 214
—0.07 214
0.11 213
0.00 214
0.04 214
0.01 214
0.03 0.2
—0.21
—0.06
0.43
0.01
0.12
0.05
0.01
25.4
25.9
31.6
32.1
33.0
29.6
1.6
2.28 202
1.75 207
1.56 207
1.43 207
3.69 193
2.14 203
0.41 2.7
6.75
4.49
4.48
5.14
8.89
5•95a
0.84
21.0
21.8
27.4
29.9
21.1
24.2
1.8
—0.05 214
—0.07 214
0.05 214
0.70 211
0.10 213
0.15 213
0.14 0.6
—0.13
—0.20
0.29
2.48
0.26
0.54
0.49
Abbreviations are: T. length, tubular length (mm); Area, tubular area (X iO cm2); V, perfusion rate (nl/min); iv, net water absorption
(nl/min. mm); Osm grad, osmotic gradient (mOsm/kg. H20) and Lp, hydrosmotic conductivity (x lO_6 cm/atm. sec).
a P < 0.01
Effect of CPM on Lp of IMCD isolated from DI rats
To substantiate the observation that CPM stimulated Lp of
IMCD in the absence of VP, experiments were performed in
Brattleboro homozygous rats with DI in which the plasma
concentration of VP is undetectable [28]. Table 4 shows that in
five consecutive experiments, CPM l0 M added to the bath
was able to increase net water absorption from 0.01 0.03
nl/min. mm to 2.14 0.41 nI/mm mm reversibly in the IMCD
of DI rats, which represents an increase in Lp from 0.05 0.01
to 5.95 0.84 (P < 0.01).
It is well known that the administration of CPM potentiates
the anti-diuretic effect of VP in DI rats [8—10]. However, there
is some doubt whether CPM is able to increase the VP-
stimulated water transport in the IMCD [29, 301. To answer this
question, we measured the Lp of IMCD of DI rats in the
presence of CPM, and after a recovery period we determined
the effect of 3 x 1013 or 3 x l0_12 M of VP. After this, we
compared the determined Lp with the values observed when
CPM was added to VP in the bath fluid. The data presented in
Figure 4 clearly show that CPM was able to increase LP
reversibly to values close to the observed with 3 x 1013 M of
VP. However, the addition of CPM to VP in the bath did not
change the Lp, which indicated that this drug did not potentiate
the VP-stimulated water permeability in the IMCD.
Effect of chiorpropamide on the '4C-urea lumen-to-bath
permeability (Pu x 1O cm/sec) of IMCD
The effect of CPM on Pu of IMCD obtained from water-
loaded Wistar rats was determined. In five consecutive exper-
iments, it was observed that CPM (10 M) in the absence of VP
was able to increase Pu from 13.5 0.8 to 17.3 1.0 which
returned to 13.5 0.7 when this drug was withdrawn from the
bath (Table 5). The stimulating effect produced by CPM repre-
sents 16% of the maximum stimulating effect produced by
10— M of VP is illustrated in Figure 5.
Discussion
The studies on the mechanism of CPM's antidiuretic action
were performed using; first, clearance studies in DI and water-
loaded patients and in DI rats [1—5, 29]; second, determination
of cAMP, adenyl-cyclase and phosphodiesterase activity in
renal medullary tissues of DI rats and toad bladder [8, 12—14,
161; third, measurements of PGE2 urinary excretion and syn-
thesis [15, 301; fourth, in vitro determination of Lp in toad
bladder [11, 12]. However, these studies did not provide us with
a definitive conclusion about the antidiuretic mechanism of
CPM. The most widely held view obtained from these studies
appears to be that CPM potentiates the antidiuretic effect of VP.
This conclusion is based mainly on the observations in DI rats
where the antidiuretic action of CPM occurs only in the
presence of submaximal concentrations of VP and in vitro
studies in toad bladder where high concentrations of CPM
(10 M) potentiates the effect of VP-stimulated Lp [9, 10, 14].
The present study shows for the first time a direct effect of
CPM on the Lp and Pu in the rat IMCD. CPM added to the bath
fluid stimulated water and urea transport in water-loaded and
DI rats. These effects were entirely reversible.
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The CPM present in the plasma reaches the IMCD by the
luminal side due to urinary excretion (20%) and peritubular side
by the medullary circulation. However, in the present study,
high concentrations of CPM (i0— M) in the perfusion fluid were
unable to stimulate Lp of IMCD, showing that the tubular
response is side dependent.
The possibility that the observed effect of CPM on Lp of
IMCD in vitro is also present in vivo could be analyzed by
determination of the therapeutic plasma levels of CPM. Me-
lander et al [281, measuring the serum CPM concentrations by
selective and sensitive gas chromatography in 60 patients,
despite dosage variations of 125 to 500 mg daily, observed
plasma variations of 50 to 500 jimollliter, which represents in
our study a bath fluid concentration capable of maximally
stimulating Lp and urea permeability in vitro. Therefore, the
minimum concentration of CPM capable of stimulating Lp
(10—6 M) was within the pharmacological range of CPM. Also,
we observed that the progressive increase in bath fluid concen-
tration of CPM determined a progressive increase in Lp.
Due to the possible presence of small concentrations of VP in
the renal tissue, we substantiate the observation of a direct
action of CPM of Lp studying the IMCD of DI rats. Homozy-
gous DI rat of the Brattleboro strain has been shown to be
completely deficient in biologically active vasopressin and its
neurohypophysis is devoid of stored VP [271. Also, in this rat
strain, CPM added to the bath fluid increases the Lp of IMCD
which was associated with the corticopapillar sodium gradient
[18], and the chloride absolute reabsorption in the Henle's loop
[31, 321 also stimulated by CPM appears to be sufficient for
CPM administration in DI rats to reduce the urinary volume in
absence of VP.
It is important to point out that the direct maximum effect of
CPM (l0— M) on IMCD had a similar magnitude to 3 x 10— 12
M of VP (Fig. 2), which corresponds to 30% of the maximum
VP-stimulated Lp. This magnitude of the Lp corresponded to
maximum VP-stimulated Lp in the rabbit IMCD which has the
concentration capacity of 800 to 1200 mOsm/kg water [311.
There is general agreement that CPM potentiates VP' s anti-
diuretic effect in DI rats, which would make it appear likely that
one mechanism of CPM's effect in DI rats is through potentia-
tion of the action of small amounts of VP in the renal tubule [9,
101. The action of CPM in potentiating the effect of VP could be
due to enhanced antidiuresis or to prolongation of the effective-
ness of VP. In the present study, we analyzed the capacity of
CPM (l0 M) to potentiate submaximum effective doses of VP
(3 X iO M or 3 x 10— 12 M) on Lp of IMCD. Contrary to what
was predicted by the clearance studies, we observed that the
combination of CPM with VP did not increase the effect of VP
on water transport in the IMCD. Thus, the potentiation of VP
observed in vivo should be through the combination of CPM-
stimulated water and urea transport of IMCD with some other
effects of VP on other tubular segments or renal hemodynam-
ics.
The final cellular events involved in the action of VP on water
transport in the IMCD consist of an increase in water perme-
ability in the apical region of the cell. Activation of adenyl-
cyclase and subsequent generation of 3'S' cAMP is necessary
for this to occur [33]. To determine whether the action of CPM
on water permeability is prior to or after cAMP formation,
several studies were performed in toad bladder and microdis-
sected medullary collecting tubules [8, 34—36]. There is no
evidence that CPM sensitizes collecting tubules to the action of
VP, at the cAMP generation step.
PGE2 has been said to be involved in VP-potentiating effects
of CPM [37, 38]. Ozer and Sharp [12] proposed that CPM
decreases the inhibitory effect of PGE2 on VP-dependent gen-
eration of cAMP. The results of the present study indicate that
CPM was unable to block the inhibitory effect of POE2 on
VP-stimulated Lp of IMCD. This observation rules out the
possibility of CPM antidiuresis being due to a modulating action
on the inhibitory effect of PGE2 on VP-stimulated water trans-
port in the IMCD. On the contrary, POE2, similarly to what we
have described with VP [ 24], inhibited the CPM-stimulated
effect on water permeability in the rat IMCD.
In summary, the present study shows clearly that CPM in
pharmacological doses added to the peritubular side has a direct
effect on the IMCD, increasing the water and urea permeability
in the absence of VP and that the antidiuresis produced by CPM
in DI rats treated with submaximal concentrations of VP cannot
be explained by potentiation of CPM on the VP-stimulated
water reabsorption in the IMCD. Besides, we did not confirm
the hypothesis that CPM potentiates the VP antidiuresis by
inhibition of POE2 action in the IMCD.
10
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2
0
Fig. 4. Absence of potentiated effect of chiorpropamide (CPM) (10--
M) on the arginine vasopressin (VP) (3 X M or 3 x 10—12
M)-stimulated hydraulic conductivity (Lp) of IMCD obtained from
diabetes insipidus (DI) rats. Each IMCD was studied during 7 consec-
utive periods: control, in the presence of CPM in the bath, recovery
period, in the presence of 3 x io' M (t) or 3 x 10—12 M () of VP in
the bath, when CPM (10 M) was added to VP in the bath, when CPM
was withdrawn and VP remained, and finally in the recovery period
(REC). Each point represents the mean of three collections which
correspond one period. Lines connect data points of individual tubules.
0.01
Control CPM Rec VP VP + VP Rec
CPM
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Table 5. Effect of chiorpropamide added to the bath fluid on urea permeability in the IMCD of W istar rats
Control Chiorpropamide Recovery
Exp T. length Area V1 Pu V1 Pu V1 Pu
1
2
3
4
5
6
Mean
3.5
2.7
3.0
3.1
3.7
2.5
3.1
0.2
26.8
24.8
20.0
23.7
30.1
28.9
25.7
1.5
26.5
27.6
27.5
28.4
28.1
28.4
27.7
0.3
13.0
16.0
14.7
11.2
11.5
14.8
13.5
0.8
27.9 17.9
27.5 18.9
27.7 20.2
28.9 13.5
28.0 16.0
28.3 17.6
28.0 17.3a
0.2 1.0
28.0
27.7
27.4
28.2
27.9
28.1
27.9
0.1
14.5
15.8
14.0
11.5
11.6
13.5
13.5
0.7
Abbreviations are: T. length, tubular length (mm); Area, tubular area (x104 cm2); V,, perfusion rate (nI/mm); Pu, urea permeability (x l0
cmlsec).
a P < 0.01
OL.
Control Exp Recovery
Fig. 5. Effect of chiorpropamide (CPM) on the lumen-to-bath urea
permeability (Pu) of IMCD obtained from Wistar rats. The values
obtained with CPM (l0 M) are compared with the maximum effect of
vasopressin (VP) (10_to M) stimulated urea permeability. Each point
represents the mean SEM of the values obtained in each period. Lines
connect data points of each experimental group. 0.01, < 0.05;
N = 6 in each group.
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